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1INTRODUCTION
In response to the widespread consumption of ethanol and the med
ical problems related to its abuse, the world literature on ethanol
metabolism has become voluminous. The interaction between the metabolism
of ethanol and intermediary metabolism of carbohydrates has been amply
elucidated. One particular very important aspect of this ethanol-carbo-
hydrate interaction which has only recently begun to be investigated is
the effect of ethanol on glucose tolerance. The preliminary studies
concerning the effects of ethanol on glucose tolerance have provided both
exciting findings and unanswered questions. This dissertation, examining
the effects of ethanol on glucose tolerance and insulin secretion, is an
attempt to share in the excitement of, and contribute to the understanding
of, this important ethanol-carbohydrate interaction.
REVIEW OF THE LITERATURE
THE EFFECTS OF ETHANOL ON BLOOD GLUCOSE CONCENTRATION:
The available data indicates that ethanol may exhibit, depending on
the nutritional status of the organism, a hyperglycemic or a hypoglycemic
effect. In the well-fed organism, the predominant effect is hyperglycemic
(attributed to ethanol's ability to increase hepatic glycogenolysis and/or
decrease peripheral glucose utilization). In the fasted organism, the pre
dominant effect is hypoglycemic (attributed to ethanol's ability to decrease
hepatic gluconeogenesis) . Well-fed organisms are those which have been
fasted no more than twelve hours and they therefore have adequate hepatic
stores of glycogen. The fasted organisms are those which have been fasted
for twenty four to seventy two hours and therefore they have Inadequate
hepatic stores of glycogen.
Well-fed organisms:
There is a slight, transient increase in blood glucose following
12 3
ethanol administration in well-nourished organisms.
' In humans, etha
nol raises the blood glucose level 7-10%, with the peak glucose level
4 5
occurring within 1/2-3/4 hour after the single ethanol dose.
'
Both the rate of glucose production and the rate of glucose utiliza
tion contribute to the blood glucose concentration. There is evidence
that ethanol can decrease peripheral utilization of glucose by 25% in dogs
fasted two to three days. It is not known if this effect is observed in
well-fed animals. Perhaps acetate derived from ethanol metabolism is meta
bolized preferentially in the peripheral tissues, thus diminishing peripheral
glucose utilization.
3The hyperglycemic effect, observed in well-fed organisms, is depen
dent upon an adequate supply of hepatic glycogen. Animals depleted of
hepatic glycogen do not demonstrate a hyperglycemic effect after ethanol
challenge. The rise in blood glucose accompanying ethanol ingestion has
been attributed to the release of epinephrine which in turn increases hepa-
7 8
tic glycogenolysis. ' It has been suggested that acetaldehyde, a product
of ethanol metabolism, is responsible for stimulating catecholamine release
9 10
from the adrenal medulla. '' In vitro evidence suggests that ethanol
stimulates hepatic phosphorylase, a finding consistent with ethanol's
glycogenolytic effect.
Perhaps ethanol stimulates glucagon secretion or secretion of chem
icals other than epinephrine which are capable of activating the adenyl
cyclase system and enhancing hepatic glycogenolysis in a liver laden with
glycogen. Present information is not available to exclude this possibili
ty. (The ability of ethanol to stimulate the adenyl cyclase system in the
beta cells of the pancreas will be explored in the "Discussion" section.)
Fasted organisms:
It has been convincingly established that ethanol-induced metabolic
changes inhibit gluconeogenesis in the liver. Ethanol itself does not in
hibit gluconeogenesis. Inhibition of gluconeogenesis is dependent upon the
hepatic oxidation of ethanol by alcohol dehydrogenase (ADH) and upon the
concomitant increase in the NADH:NAD ratio.
NAD+ + CH_CH OH ^* NADH + H+ + CH CHO
The activity of ADH in liver slices is dependent upon the ethanol con-
412
centration. The above ADH-mediated reaction proceeds at its maximal
rate at an ethanol concentration of 8 millimoles in the incubation medi-
13
urn.
"
This is almost exactly the same ethanol concentration that impaired
gluconeogenesis from lactate maximally in independent studies with the
14
perfused rat liver. These findings strongly suggest that the degree of
inhibition of gluconeogenesis with ethanol is directly related to the
activity of the enzyme ADH. This conclusion is further supported by the
observation that gluconeogenesis is not inhibited by ethanol in the cortex
of the kidney, an organ which is devoid of ADH.
"
Also confirmatory is
the fact that Pyrazole, a specific inhibitor of ADH, reverses the inhibi
tion of gluconeogenesis by ethanol.
Under physiological conditions in the postabsorptive or fasting state,
lactate, glycerol and amino acids are the major precursors of glucose pro
duction. Lactate must first be oxidized to pyruvate before it is ulti
mately converted to glucose. A consistent increase in the plasma lactate:
pyruvate ratio is observed as a result of ethanol metabolism. This may be
a reflection of increased hepatic production of lactate or decreased hepatic
uptake of lactate.
Krebs showed that ethanol decreased by approximately 66% the rate of
14 15
gluconeogenesis from lactate in the perfused rat liver. ' He attributed
this to increased hepatic production of lactate. The following important
reaction, catalyzed by lactic dehydrogenase, occurs in the cytoplasm of
the hepatocyte:
lactate + NAD -{ j pyruvate + NADH + H
Krebs attributed the inhibition of gluconeogenesis from lactate to an
increase in the NADH:NAD ratio. An increase in this ratio is accompanied
5by an increase in the lactate :pyruvate ratio. Ethanol administration can
increase the normal lactate: pyruvate ratio of 10-20 to as much as 100.
The increased lactate :pyruvate ratio reflects a fall in the pyruvate con
centration rather than a rise in the lactate concentration. A fall in the
steady state concentration of pyruvate will critically decrease the rate
of one of the rate-limiting reactions of gluconeogenesis.
pyruvate —py . =—» oxaloacetate » > » glucosecarboxylase
Pyruvate carboxylase has a K for pyruvate of about 0.4mM. The normal
pyruvate concentration in the liver in vivo is about O.lmM or less. This
implies that the rate of the above reaction is dependent upon the pyruvate
concentration. By lowering the steady state concentration of pyruvate and
hence, impeding the pyruvate carboxylase reaction, ethanol can effectively
inhibit gluconeogenesis from lactate.
In isotopic studies on human volunteers, Kreisberg has demonstrated a
18
decrease in lactate utilization with ethanol. Measuring splanchnic lac
tate production in humans, other investigators also concluded that ethanol
19
decreased lactate removal by the liver. Whether ethanol increases hepatic
production of lactate or decreases hepatic utilization of lactate, the net
effect is the same: lactate is prevented from entering into gluconeogenic
pathways .
When ethanol was added to the perfusion medium of rat liver, a marked
14 15
inhibition of gluconeogenesis from glycerol was observed. Several
authors have consistently demonstrated an accumulation of ot-glycerophosphate
1 / 0C\ 01 0 0 0 0
in liver tissue bathed in ethanol. ' ' ' ' The increase in the NADH:
NAD ratio observed in ethanol metabolism is accompanied by an increase in
6the oc-glycerophosphate: dihydroxyacetonephosphate ratio. This shift favors
the formation of triglycerides from ^-glycerophosphate at the expense of
glucose formation from dihydroxyacetonephosphate.
dihydroxy-
acetoneglycerokinase ©^-glycerophosphate
glycerol > ^-glycerophosphate + NAD — >
j dehydrogenase MAnH _,. H+
I
NADH + H
I
1
i I
triglycerides glucose
AMP has been shown to strongly inhibit the activity of hepatic glycero-
24
kinase. If ethanol is added to the incubation medium at a concentration
which will result in 50% inhibition of glycerol consumption by the liver
24
slices, then the AMP concentration will have increased three to five fold.
It has been convincingly shown that ot-glycerophosphate is an inhibitor of
25
glycerokinase. Glycerol infusions in humans resulted in a 30% decrease
23
uptake of glycerol by the liver in the presence of ethanol.
Therefore ethanol may inhibit gluconeogenesis from glycerol by impeding
the conversion of glycerol to ot-glycerophosphate as well as by impeding
the conversion of oc-glycerophosphate to dihydroxyacetonephosphate.
Krebs has shown that ethanol inhibits gluconeogenesis from the amino
14
acids alanine and serine in the perfused rat liver. He attributes this
to the conversion of alanine and serine to pyruvate which, in the presence
of ethanol, is shunted to lactate instead of to glucose. In fact, lactate
production from alanine and serine did increase in the presence of ethanol.
It has been demonstrated, using the isolated perfused rat liver, that
ethanol interferes with glucose formation but not with amino acid mobiliza-
7tion, thus suggesting a block in oxidative deamination of amino acids, not
26
a block in protein breakdown. Several amino acids are deaminated (before
being utilized for gluconeogenesis) by the transfer of the amino group to
c-ketoglutarate with the formation of glutamate and the corresponding
o^-keto acid. Glutamate is then oxidatively deaminated to «:-ketoglutarate
by glutamic dehydrogenase. Glutamic dehydrogenase has been shown to be
NH.
ot-amino acid
(eg. alanine)
<*-ketoglutarate NADH + H
transaminase
ot-keto acid
(eg. pyruvate)
glutamate
dehydrogenase
glutamate NAD
27
dissociated into inactive units by NADH. It is not surprising that gluco-
28
neogenesis from glutamate was inhibited by ethanol. The inhibition of
gluconeogenesis from proline can be explained by this formulation, since
proline must first be converted to glutamate to be glucogenic.
Several amino acids (valine, methionine, isoleucine, lysine) are de
aminated to ot-ketoglutarate or succinate which are metabolized in the
citric acid cycle to malate and oxaloacetate. These latter two substances
may then enter into gluconeogenic pathways . Ethanol has been shown by
numerous authors to decrease citric acid cycle activity, presumably through
29 30 31
an inhibition of reactions that are accompanied by a reduction of NAD. ' '
The oxidation of ethanol and the concomitant increase in NADH provide
a number of metabolic blocks in the biochemical pathways of gluconeogenesis
from lactate, glycerol and amino acids.
In the starved organism (depleted hepatic glycogen stores), the blood
glucose concentration is mainly dependent upon hepatic gluconeogenesis.
In the presence of ethanol, an inhibitor of gluconeogenesis, hypoglycemia
may ensue. The administration of ethanol to animals fasting for 2-3 days
32 33
invariably resulted in a significant lowering of the blood sugar.
The same phenomenon was observed in normal subjects fasting for a similar
period. ' In both man and in dogs, the ethanol-induced hypoglycemia
was not associated with a rise in plasma insulin concentration. Both the
liver biopsy and the lack of response to glucagon confirm the absence of
liver glycogen in both humans and experimental animals. '
36
In 1941, Brown and Harvey first described ethanol-induced hypo
glycemia as a distinct clinical syndrome, based on observations of six
malnourished chronic alcoholics. Since then, numerous cases have been
reported as the syndrome has become more familiar to physicians. In a
37
review of this clinical syndrome, Madison concluded that hepatic glycogen
depletion, from whatever cause, was the major predisposing factor in ethanol-
induced hypoglycemia. In the absence of hepatic glycogen, glucose produc
tion is dependent upon gluconeogenesis. When gluconeogenesis is acutely
inhibited by ethanol, glucose production can not keep up with glucose util
ization and hypoglycemia ensues.
THE EFFECTS OF ETHANOL ON GLUCOSE TOLERANCE:
Metz has recently shown that, in a group of normal volunteers, the
administration of ethanol prior to a glucose load lowers the blood glucose
38
rise and increases the early insulin response. Shortly thereafter, Fried-
enberg and Metz obtained similar results in a group of normal controls and
39
in a group of noninsulin-dependent diabetics. Studying patients with a
history of diabetes mellitus or a strong family history of diabetes, Phillips
found that ethanol pretreatment resulted in a deterioration of glucose
tolerance (i.e. an exaggerated blood glucose rise In response to a glucose
40
load) in association with an increased insulin secretory response. When
ethanol and the glucose load were administered simultaneously to a group
of healthy volunteers, Dornhorst observed a deterioration in glucose toler-
41
ance in association with an increased insulin secretory response.
Metz employed the intravenous glucose tolerance test at 8 A.M. after
a 12 hour fast (during which time the subjects were awakened every two hours
38 39
to ingest the ethanol). ' Phillips, administering very large amounts of
ethanol (approximately one half liter of pure ethanol) over a two to three
day period, performed the glucose tolerance test at 8 A.M. after a 12 hour
40
fast. Dornhorst administered the ethanol and glucose simultaneously at
41
8 A.M. after a 12 hour fast.
10
OBJECTIVE
In the studies previously mentioned, there is conflicting data regard
ing the effect of ethanol on glucose tolerance. It is the objective of this
study to examine this effect in diabetic and nondiabetic volunteers in cir
cumstances which more closely approximate the usual mode of ethanol intake.
11
MATERIALS AND METHODS
Eight nondiabetic and six diabetic subjects were studied. One dia
betic and one nondiabetic were excluded from the data on the basis of a
flat glucose curve, presumably secondary to malabsorption of glucose.
(see "Discussion" section)
Four men and three women between the ages of nineteen and twenty eight
(mean twenty two) comprised the normal nondiabetic group. In this group,
there was no history of liver disease, ethanol abuse, diabetes mellitus or
family history of diabetes. No subject had been taking any medications
prior to or during the course of the study. All subjects were within 7%
of their "desirable weight" (Metropolitan Life Insurance Company: Statis
tical Bulletin, 40: 3, 1959). None of the female subjects were studied
close to or during their menstrual periods.
Three men and two women between the ages of thirty two and fifty
eight (mean forty four) comprised the diabetic group. There was no history
of liver disease or ethanol abuse in this group. None of the subjects in
this group were on insulin therapy during the study nor at any time during
the twelve months prior to the study. Four of the five subjects were
receiving oral hypoglycemic agents which were discontinued the day before
each glucose tolerance test. None of the subjects in this group were
taking any other medications prior to or during the course of the study.
All subjects were within 12% of their "desirable weight" (Metropolitan
Life Insurance Company: Statistical Bulletin, 40: 3, 1959). Neither
female subject was studied close to or during her menstrual period.
Both the diabetics and nondiabetics were involved in the same exper
imental design. For the three days prior to the test, each subject was
12
instructed to consume a well-balanced diet containing at least 200 grams
carbohydrate per day. Two tests separated by one week were performed on
each subject. During one test, ethanol was administered prior to the glucose
tolerance test and, during the other test, noncalorie soda replaced the
ethanol. The subjects were randomized so that half of them received ethanol
first and half received noncalorie soda first. On the day of the test, a
standardized lunch containing 40% carbohydrate was administered. Over the
next four hours, each subject ingested either 60 ml of ethanol as 80 proof
whiskey in water divided into equal hourly doses or equal volumes of non
calorie soda. 100 grams dextrose was then administered orally. Venous
blood samples for glucose, insulin and glucagon determinations were obtained
during the hour prior to, and during the three hours after, the ingestion
of dextrose. An outline of the experiment is as follows:
12:00 P.M. -300 standardized lunch (40% carbohydrate)
1:00 P.M. -240 15 ml ethanol as 37.5 ml 80 proof whiskey in 3 oz. water *
2:00 P.M. -180 (
" ) *
3:00 P.M. -120 (
" ) *
4:00 P.M. -60 (
" ) *
4:05 P.M. -55 blood sample for glucose, insulin and glucagon
4:30 P.M. -30 (
" )
4:55 P.M. -5 ( )
5:00 P.M. 0 100 grams dextrose
5:15 P.M. +15, 30, 45, 60,
to 75, 90, 105, blood sample for glucose, insulin and glucagon
8:00 P.M. 120, 150, 180
* or an equal volume of noncalorie soda on the other test day
(blood samples for ethanol determinations were obtained at -5, +60, +120, +180)
13
Plasma glucose was determined by the glucose oxidase procedure.
Plasma Insulin was measured by radioimmunoassay, employing talc to separate
bound and free insulin. Pancreatic glucagon was measured in plasma by
radioimmunoassay, with an antibody (lot 30K) made available by Dr. Roger
44 45
Unger. The ethanol concentration was measured spectrophotometrically.
46
The paired t-test was employed in the statistical analyses. All values
reported are +standard error of the mean (SEM) -
14
RESULTS
The peak blood ethanol concentration in the nondiabetics occurs at
-5 minutes and is 29+4 mg%. In the diabetics, it also occurs at -5 minutes
and is 35+7 mg%. All of the subjects tolerated the ethanol well. Some
experienced mild transient nausea after its ingestion. None showed evi
dence of inebriation.
NONDIABETICS :
Ethanol has no effect on the baseline glucose concentration but there
is a significant depression of the blood glucose rise in the ethanol-
treated group (Fig. 1). Glucose levels are 30-40 mg% lower in the ethanol
group at 30-90 minutes after glucose ingestion. After 30 minutes the two
curves are significantly different (p<.025). The peak glucose concen
tration occurs at 45 minutes in each group. It is 126+17 mg% in the eth
anol group and 161+18 mg% in the control group (p <.005). The two curves
are also significantly different at 60 and 90 minutes (p <.05).
Ethanol has no significant effect on the baseline insulin concen
tration (Fig. 2). There is an increase in the early insulin response to
the ingestion of an oral glucose load in the ethanol group. The peak
insulin concentration is the same in both groups (66+12 microunits per ml
in the ethanol group and 66+12 microunits per ml in the control group) ,
but the peak occurs 60 minutes earlier in the ethanol group (45 minutes
in the ethanol group and 105 minutes in the control group). In the ethanol
group, the insulin concentration is significantly higher at 45 minutes
(p<..05) and is significantly lower from 75 to 150 minutes (p<.05).
180'
160.,
140 ..
Glucose
(mg%)
120 4
100 ■ ■
80 ■-
FIGURE 1
GLUCOSE (Nondiabetics)
o o = control
d O = ethanol
T = SEM
T
100 grams dextrose
+60
time (min.)
+120 +180
70 "■
60 "
50
Insulin
(micro-
units /ml)
40 -
30
20
FIGURE 2
0~^~~^0 = control
□ £J = ethanol
= SEMT
time (minutes)
+60
1
+120
—1
+180
1—
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In figure 3, the insulin secretory response is expressed as the sum of
the plasma insulin concentrations in the first three post-glucose blood
samples (and in the next three samples and last four samples). The initial
insulin secretory response (15-45 minutes) is 40% higher in the ethanol
group (p <.05) and the late insulin response is significantly higher in the
control group (p<.005).
250 •■
200 "
Insulin
(micro-
units/ml)
150
100
50 ■-
15+30+45 min.
(p<.05)
= 2 times SEM
60+75+90 min. 105+120+150+180 min.
(p <-05) (p <.005)
C E C E C E
SUM OF THE INSULIN CONCENTRATIONS (C=control group, E=ethanol group)
FIGURE 3
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In figure 4, the insulin secretory response is expressed as the sums
of increments of insulin (i.e. the summation of the increases of insulin
over baseline). Expressed in this way, the same effect observed in figure 3
is clearly demonstrated here.
250
200..
Insulin
(micro-
units/ml)
150..
100- .
50-
15+30+45 min.
(p<-05)
= 2 times SEM
60+75+90 min.
(p<.025)
105+120+150+180 min.
(p <:.0025)
■ "
C E C E C E
SUM OF THE INCREMENTS OF INSULIN (C=control group, E=ethanol group)
FIGURE 4
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In figure 5, the insulin secretory response is expressed as the total
area under the insulin response curve from zero to 60 minutes and from 60
to 180 minutes. (The area is calculated geometrically by summing the area
of the trapezoids described by the insulin response curve.) Expressed in
this way, the data is again consistent and statistically significant.
60 to 180 minutes
(p <.025)
C E C E
AREA UNDER THE INSULIN RESPONSE CURVE (C=control group, E=ethanol group)
FIGURE 5
To evaluate the insulin response as a function of a glycemic stimulus,
47 it
Seltzer popularized the expression, insulinogenic index which is a ratio
of the insulin increment to the glucose increment. In figure 6, the insulin:
20
glucose ratio (I:G ratio) is defined as the total area circumscribed by the
insulin curve divided by the total area circumscribed by the glucose curve
(over a given time interval). Over the first 60 minutes, the I:G ratio is
significantly higher in the ethanol group (p <.0125). In the ethanol group,
the early insulin responses are out of proportion to the glycemic stimuli.
During the last 120 minutes, there is no significant difference in the I:G
ratio between the control and ethanol groups.
I:G ratio
(micro-
units /mg)
0 to 60 minutes 60 to 180 minut es
(p <.0125) NS
_
40 . = 2 times SEM
-■
o
7
|
-.
' 1
20 .
C E C E
I:G RATIO (C=control group, E=ethanol group)
FIGURE 6
Baseline glucagon levels in the control and ethanol groups are not sig
nificantly different (Fig. 7). Glucose suppression of glucagon is demon
strated in both groups. All post-glucose ingestion glucagon levels fall
25-40% below baseline values in both the ethanol and control groups (p *.005)
Glucagon levels are significantly higher in the ethanol group at 45 minutes
(p 4.05), 75 minutes (p <.025) and 90 minutes (p <.01).
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DIABETICS:
Ethanol has no effect on the baseline glucose concentration but ethanol
does dampen the blood glucose rise following the ingestion of glucose (Fig. 8).
Glucose levels are 40-80 mg% lower in the ethanol group at 90-180 minutes
after glucose ingestion. The two curves are significantly different at
105 minutes (p < .0125) , 120 minutes (p <.005), 150 minutes (p 4.005) and
180 minutes (p <.025).
Ethanol has no significant effect on the baseline insulin concentration
(Fig.9). The initial insulin response is higher in the ethanol group.
The peak insulin concentration is higher in the ethanol group (25+5 micro-
units per ml vs 20+6 microunits per ml) and occurs earlier in the ethanol
group (30 minutes vs 90 minutes). The two curves are significantly differ
ent at 15 minutes (p <.025) and at 30 minutes (p 4.025).
Expressed as the sura of the plasma insulin concentrations (Fig. 10),
the early insulin response (15-45 minutes) is 35% higher in the ethanol
group (p 4.025). Expressed as the area under the insulin response curve
from zero to 60 minutes (Fig. 11), the insulin response is again 35% higher
in the ethanol group (p<.0125).
The I:G ratio is significantly higher in the ethanol group over the
first 60 minutes (p <.0125) and over the last 120 minutes (p 4.01), indi
cating that ethanol enhances glucose-mediated insulin secretion during the
entire three hours (Fig. 12).
Glucagon samples were obtained but were not analyzed at the time of
this writing.
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DISCUSSION
The data presented here indicate that ethanol intake lowers the blood
glucose rise and increases the early insulin response to the ingestion of
an oral glucose load. The mechanisms responsible for these two effects are
not readily apparent and are worthy of further consideration.
The concept that a particular substance can enhance glucose-mediated
insulin secretion is not new. There are numerous instances in which two
or more agents act synergistically to enhance insulin secretion. A com
bination of glucose-glucagon-tolbutamide has been shown to raise the plasma
insulin concentration to 450 microunits per ml; yet the plasma insulin
concentration was less than 100 microunits per ml when stimulated by any
48
one of these agents alone. Leucine has a small and inconsistent effect
on blood glucose but prior treatment with a sulfonylurea markedly enhances
49
the leucine-induced rise in insulin and fall in glucose.
In the two examples just cited, all of the agents are insulin secret
ogogues, i.e. are capable by themselves of raising the plasma insulin con
centration. However, a number of agents are not capable by themselves of
significantly affecting the plasma insulin concentration, but in combina
tion with a known insulin secretogogue, they are capable of enhancing the
effect of the insulin secretogogue. For example, the anabolic steroid meth-
andienone has no effect on plasma insulin levels, but prior administration
of methandienone enhances the tolbutamide-induced insulin response three
fold. Galactose pretreatment enhances the glucose-induced insulin re
sponse in individuals with galactosemia while galactose alone is not an
51 52
insulin secretogogue. ' Salicylates cause a small but significant rise
in plasma insulin (5-10 microunits per ml) but when administered prior to
28
a glucose load, salicylates augment the glucose-mediated insulin response
53
approximately 60 microunits per ml.
Metz was the first to describe the ability of ethanol to lower the
blood glucose rise and to increase the early insulin response to a glucose
38
load. He observed this effect with both orally and intravenously admin
istered ethanol. He concluded that a gastrointestinal factor, humoral or
neural, was probably not involved since the effect was independent of the
route of administration of the ethanol.
In an attempt to explain the effects of ethanol observed in this study,
it is important to consider the effects of ethanol on the stomach and in
testine, liver and pancreas. An alteration in gastrointestinal or hepatic
or pancreatic homeostasis or a combination of these may contribute signifi
cantly to the observed effects of ethanol on glucose tolerance and insulin
secretion.
GASTROINTESTINAL FACTORS :
In doses and concentrations comparable to the ones used in the present
study, ethanol has been shown to slow the emptying of the stomach. Employ
ing the barium meal under fluoroscopy in healthy human subjects, it was
found that orally-administered ethanol delayed gastric evacuation up to
54
twice the control time. Under fluoroscopic visualization, there appeared
to be an increase in peristalsis and tonus with lack of coordination in the
ethanol-treated volunteers. A few years later, other investigators, using
similar techniques, found that the average emptying time of the stomach
increased from three hours without ethanol to almost six hours with oral
ethanol treatment. The delayed gastric emptying was attributed to pyloro-
spasm secondary to irritation of the gastric mucosa. It has been shown in
rats that parenteral ethanol, administered before the glucose load, de
creases the absorption of orally-administered glucose as a result of a
delay in gastric emptying secondary to pylorospasm.56 '57 Pylorospasm in
this case was attributed to a central, not a local, action of ethanol.
The oral administration of ethanol to rats was found to slow gastric evac
uation by paralyzing the musculature of the stomach wall, presumably via
a local effect. ' It will be substantiated later that ethanol enhances
the amount of acid delivered to the duodenum. Acid bathing the duodenal
mucosa initiates a neurally-mediated decrease in gastric motility, the
enterogastric reflex. Acid in the intestine also stimulates enterogastrone
which weakly inhibits gastric motility. Ethanol also has been shown to
inhibit glucose absorption in the isolated small intestine of the rat.
Both oral and intravenous ethanol are capable of inducing nausea and
vomiting. The emetic action of ethanol is complex and may involve both
the central nervous system and autonomic nervous system. Gastric distension
is associated with nausea and vomiting. Perhaps gastric distension pro
duced by ethanol manifests itself by the symptom and sign of nausea and
vomiting. In support of this hypothesis is the observation in the present
study that approximately one third of the subjects studied (diabetics and
nondiabetics) experienced some degree of nausea after ethanol ingestion.
There was no instance of vomiting. Two of the fourteen subjects studied
(one diabetic and one nondiabetic) were excluded from the data on the basis
of a flat glucose curve and a lack of insulin response to the oral glucose
load. (a strong indication of glucose malabsorption) Of note is the fact
that the flat glucose curve occurred only after ethanol ingestion. After
the control solution of noncalorie soda, both subjects responded approp-
30
rlately to the oral glucose load with a rise in glucose and insulin con
centrations. Both of these subjects experienced nausea at some time in
the ethanol glucose tolerance test.
It is apparent that ethanol, whether administered orally or intra
venously, decreases gastric emptying. This effect may be an important
factor in lowering the blood glucose rise in response to the ingestion of
an oral glucose load.
Both Intravenous and oral ethanol are known to stimulate gastric
6 ? 6 ^
secretion of HCl. '
"
Ethanol, administered intravenously to dogs with
antrectomies, vagotomies or excisions of the whole small intestine, was
63
shown to be a strong stimulant of gastric secretion. It was concluded
that intravenous ethanol did not stimulate gastric secretion through any
of the usual, known physiologic mechanisms. Oral ethanol was shown to be
a powerful stimulant for the antral gastrin mechanism, acting in much the
same way as stimulation by food.
' Both food and ethanol stimulate
gastrin secretion from the antrum of the stomach. Gastrin circulating in
the blood stimulates gastric secretion and specifically HCl secretion from
the parietal cells of the fundus and body. The ethanol-stimulated acid
secretion from the stomach enters the duodenum where it stimulates the
release of secretin from the mucosa of the upper small intestine.
It is now clearly established that the insulin response to orally-
administered glucose is greater than the insulin response to glucose ad
ministered intravenously.
' The additional insulin released is an im
portant factor in glucose disposal. A large body of evidence has accumu
lated which implicates a hormonal mechanism for this enhanced insulin
secretion. Secretin and gastrin, two hormones present in the gastrointes
tinal tract, are both capable of stimulating insulin secretion under varying
31
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conditions. ' It has recently been shown that an amount of gastrin,
equivalent to that produced in response to a protein meal, is sufficient
to stimulate insulin secretion. An insulinotropic effect of purified
secretin and crude secretin extracts has been amply demonstrated in vivo,
employing physiological amounts of secretin. ' ' °'71'7 '73 There are
however, conflicting reports concerning the ability of endogenous secretin,
provoked by intraduodenal instillation of acid in man, to stimulate insulin
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secretion appreciably. The major problem in evaluating the insulino
tropic effect of secretin is the lack of a reliable assay for secretin.
Perhaps all or part of the augmented insulin response with ethanol is
due to gastrin or secretin release. Perhaps a combination of gastrin-
glucose or secretin-glucose or gastrin-secretin-glucose acts synergistically,
just as in the examples previously sited, to augment the insulin response.
Glucagon is another hormone that may be a partner in this synergism. In
nondiabetics, baseline and post-glucose ingestion glucagon levels are con
sistently higher in the ethanol group although statistical significance is
only achieved at 45, 75 and 90 minutes (p 4.025). The pancreatic glucagon
assay employs a highly sensitive glucagon antiserum which cross reacts very
44
weakly with extracts of gastrointestinal tissue. It measures essentially
pancreatic glucagon with a negligible amount of glucagon-like reactivity
of gastrointestinal origin being measured. Perhaps the small increment in
the glucagon levels in the ethanol group is a reflection of a small pancre
atic glucagon increment or perhaps a very large enteric glucagon release,
either of which may be a partner in the gastrin-secretin-glucose synergism.
Both pancreatic and enteric glucagon, in very large amounts, are capable
,, ■, ., < u *■ 76,77,78
by themselves of stimulating insulin secretion.
32
HEPATIC FACTORS:
The increased release of insulin in the ethanol group may represent
increased pancreatic secretion or decreased hepatic removal. Insulin is
released from the pancreas into the portal circulation where approximately
79fifty per cent of it is removed in one transhepatic circulation. The
80
liver plays a central role in the metabolism of insulin. Insulin is
inactivated by a reductive cleavage catalyzed by a glutathione-insulin
transhydrogenase (insulinase) and a subsequent hydrolysis of the A and B
chains. The destruction of insulin can be competitively inhibited iji vivo
and in vitro and the hypoglycemic action of insulin can be increased by
peptide extracts of liver tissue which presumably contain insulinase inhi-
81
bitors. Partial acid hydrolysates of glucagon and many other peptides are
82
strong competitive inhibitors of insulinase. There is no specific evi
dence that ethanol or its metabolic products is capable of inhibiting hepat
ic insulinase. Nor has the effect of ethanol on hepatic insulin removal
been examined. Because of the profound effect of ethanol on the metabolic
events in the liver, it must remain a possibility (until the appropriate
studies are performed) that ethanol augmentation of insulin release is a
result of decreased hepatic removal Of insulin.
PANCREATIC FACTORS:
Insulin release from the beta cells of the pancreas is under the con
trol of complex regulatory mechanisms, many of which are not known. There
is increasing evidence that insulin release is affected by the level of
83
cyclic AMP within the beta cell. Cyclic AMP and hormones that increase
cyclic AMP (glucagon, epinephrine, ACTH) are able to stimulate insulin se-
83
m
cretion in the rat s pancreas in vitro. The enzyme system adenyl cyclase
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is activated in the membrane of the beta cell, where it facilitates the
conversion of ATP to cyclic AMP. Cyclic AMP in turn activates glycogen
olytic and glycolytic enzymes (phosphorylase and phosphofructokinase respec
tively) . The net effect is an increase in carbohydrate intermediates which
stimulate insulin secretion.
[ , Glucagon *Ethanol-'- - -> Epinephrine -fre"yl
ACTH Cyclase
ATP Glucose Glycogen
Phosphofructokinase i
orylase
Glucose
Metabolites
V
Insulin
Secretion
It follows that cyclic AMP can not stimulate insulin secretion in the absence
of glucose or glycogen within the beta cell. Employing the rat's pancreas
in vitro, it has been elegantly shown that stimulation of insulin secretion
by cyclic AMP or hormones that increase cyclic AMP could not be detected
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when glucose was absent or present in concentrations less that 100 mg%.
However, insulin secretion was maximal at a glucose concentration of 300 mg%.
The beta cells of the normal rat's pancreas contain no detectable glyco
gen; therefore, stimulation of the adenyl cyclase system is ineffective
in producing carbohydrate intermediates (which stimulate insulin secretion)
in the absence of glucose.
The cyclic AMP model of insulin secretion could explain the effect of
ethanol on insulin secretion. Evidence has been presented previously that
34
ethanol stimulates epinephrine secretion. The data presented on the non
diabetics suggests that ethanol stimulates pancreatic glucagon secretion
minimally. (The effect of ethanol on enteric glucagon secretion is not
known.) Although the evidence is not incontrovertible, it appears that the
acute administration of ethanol stimulates the release of ACTH.85,86 Eth
anol itself or a metabolite of ethanol or another factor stimulated by eth
anol (perhaps epinephrine, glucagon, ACTH) could activate the adenyl cyclase
system in the membrane of the beta cell, thus increasing the intracellular
level of cyclic AMP- Cyclic AMP subsequently activates phosphorylase and
phosphofructokinase. In the absence of a glycemic stimulus (steady state
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glucose concentration less than 100 mg% in one study presented ), very
minimal increases in carbohydrate intermediates are produced in the course
of glucose catabolism. Thus a very weak insulin response is observed (note
the slightly but not significantly higher baseline insulin levels in the
ethanol group—see Figures 2 and 9). The presence of a glycemic increment
(following the ingestion of the glucose load) combined with the activated
enzymes within the beta cell (following the ingestion of ethanol) result in
a rapid augmented production of glucose metabolites which stimulate insulin
secretion briskly and maximally.
Certainly ethanol may affect the pancreas through its rich nerve or
blood supply. It would be useful to know if beta cells hypertrophy after
ethanol exposure and if ethanol enhances the insulin content of the beta
cell. The paucity of data in these areas makes it difficult to formulate
conclusions based on beta cell morphology.
Summarizing the findings in this study, it is clear that ethanol lowers
the blood glucose rise to the ingestion of an oral glucose load in both dia
betics and nondiabetics. Ethanol, by its known effect on gastric motility,
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impedes the deposition of glucose into the small intestine, thus slowing
absorption. In addition, the prompt rise in insulin concentration follow
ing the glycemic stimulus accelerates the glucose disposal rate. Several
workers have shown that the major determinant of glucose disappearance is
the magnitude of the insulin released immediately after the glucose stim-
87 88
ulus. In the nondiabetics, the peak insulin response is the same in
the ethanol and control groups but the peak occurs 60 minutes earlier in the
ethanol group (Fig. 2). In the diabetics, the peak insulin response is higher
and also occurs 60 minutes earlier in the ethanol group (Fig. 9). Ethanol
clearly enhances glucose stimulation of insulin secretion. This is demon
strated by the significantly increased I:G ratios in both nondiabetics and
diabetics (Fig. 6 and Fig. 12 respectively). This effect may be due to gas
trointestinal factors (gastrin or secretin secretion) , hepatic factors (de
creased hepatic removal of insulin) or pancreatic factors (increased cyclic
AMP production) .
Ethanol alone has no significant effect on plasma glucose and insulin
concentrations in diabetics and nondiabetics. This finding is in agree-
35 38 39 89
ment with several other investigators.
' ' ' The finding that ethanol
lowers the blood glucose rise and increases the early insulin response to a
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glucose load is entirely consistent with the results of Metz and Frieden-
berg, who administered ethanol both orally and intravenously. The mech
anisms concerning gastrointestinal, hepatic and pancreatic factors previously
discussed are applicable to the intravenous as well as the oral administra
tion of ethanol. Of particular interest is the ability of intravenous eth
anol to decrease gastric motility and to enhance the secretion of gastro
intestinal hormones known to be insulin secretogogues.
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Phillips contended that ethanol causes a deterioration in glucose tol-
40
erance. (i.e. an elevated blood glucose rise in response to a glucose
load) Employing 275 ml ethanol per day (4 1/2 times the amount administered
in our study) , Phillips demonstrated a deterioration in glucose tolerance
and an increased but delayed insulin response in three subjects treated with
40
ethanol. The delayed but increased insulin response is most likely secon
dary to the elevated .blood glucose levels. Ethanol produced no effect in
three other subjects. The three subjects whose glucose tolerance deterior
ated with ethanol had a strong genetic predisposition to diabetes mellitus
and two of these three had a history of heavy ethanol ingestion. The three
subjects who did not show any ethanol effect were completely normal volun
teers. One subject, who exhibited a deterioration in glucose tolerance with
the ingestion of 285 ml ethanol in one day, was presented in detail by Phil-
40
lips. In this subject, 29 ml ethanol lowered the blood glucose rise (2
hour glucose-96 mg% vs 130 mg%) and increased the early insulin response
(peak insulin response occurred 60 minutes after the glucose load in both-
230 microunits per ml vs 116 microunits per ml) , findings entirely consis
tent with the results of this study. Phillips' data suggests that the ad
ministration of large amounts of ethanol to subjects with compromised glucose
homeostatic mechanisms causes a deterioration in glucose tolerance and that
small amounts of ethanol may improve glucose tolerance and increase the early
insulin response.
When ethanol was administered simultaneously with the glucose load,
Dornhorst demonstrated a deterioration in glucose tolerance in a group of
41
six healthy volunteers. The elevated insulin levels observed in the eth
anol group is most likely a reflection of the elevated blood glucose levels.
This data suggests that ethanol itself increases the blood glucose rise in
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response to a glucose load. Dornhorst attributes this effect to an inhibi
tion of peripheral glucose uptake. The ability of ethanol to enhance gly
cogenolysis via catecholamine release may be a contributing factor. It has
been previously mentioned that ethanol produces a transient increase in the
blood glucose level in well-nourished organisms.1,2'3
The factors responsible for the ethanol-induced lowering of the blood
glucose rise may depend upon metabolic changes brought about by the meta
bolism of ethanol. The evidence has already been presented that ethanol
itself does not inhibit gluconeogenesis but that the catabolism of ethanol
is necessary for the inhibition of gluconeogenesis in the liver. Perhaps
the factors (gastrointestinal, hepatic, pancreatic) responsible for lowering
the blood glucose rise and increasing the insulin response are contingent
upon the metabolism of ethanol. The oxidation of ethanol is a linear func-
90
tion of time. (In the adult, the average rate that ethanol can be metabol
ized is about 10 ml per hour.) In our study, approximately 40 ml of ethanol
had already been metabolized at the time of the glucose ingestion. No eth
anol metabolism had taken place at this time in the subjects of Dornhorst.
The mechanisms involved are not clear but it does appear that the timing of
the ethanol administration in relation to the glucose load is important in
assessing the effects of ethanol on glucose tolerance.
It is perhaps not inappropriate to conclude this theoretical, mechanism-
oriented discussion on a practical note. There is no doubt that physicians
have justified reservations about ethanol use in diabetics. The caloric
content of ethanol, the antabuse-like reaction, stimulation of triglyceride
formation and the risks of intoxication are all factors which must be care
fully considered. In spite of these reservations, this study suggests that
38
small amounts of ethanol, ingested at the appropriate time in relation to
meals, by the appropriate diabetic patients, may not be harmful, but in
fact may even be beneficial in dampening the exaggerated postprandial blood
glucose rise.
39
SUMMARY
Ethanol intake lowers the blood glucose rise and increases the early
insulin response to the ingestion of an oral glucose load. The data sug
gest that moderate amounts of ethanol enhance glucose-stimulated insulin
secretion and may improve glucose tolerance. Gastrointestinal, hepatic and
pancreatic mechanisms were discussed.
4i
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